November 19, 2020 - 10:30 am

From: NCCRED 

Friday 20th November 11am – 3pm

We wish we could see you all face to face, but this year it will be done virtually to accommodate COVID-19 restrictions.

The 2020 symposium will focus on innovations in therapeutic practice for methamphetamine disorder. The symposium brings together leading national researchers, including presentations from recipients of NCCRED’s Round 2 Seed Funding Program. Recipients will share the most up-to-date aspects of their work and research around methamphetamine and emerging drug use.

Register now, it’s free!

Guest International Presenter: Dr David Goodman-Meza
David Goodman-Meza, MD, MAS, is an Assistant Professor in the Division of Infectious Diseases at the David Geffen School of Medicine at University of California, Los Angeles, USA. Dr. Goodman-Meza is a Mexican-American physician-scientist.

He is a recipient of an NIDA K08 Career Development Award where he is training in the use of natural language processing and machine learning to evaluate outcomes of people who inject drugs who are admitted due to Staphylococcus aureus bacteremia. He is also the Los Angeles principal investigator on a NIDA Clinical Trials network study evaluating buprenorphine for treatment of methamphetamine use disorder.